Elys BMG Group, Inc.
ELYS
$0.0004
$0.000.00%
| Weiss Ratings | ELYS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | ELYS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | ELYS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 193.29 | |||
| Price History | ELYS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 300.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -99.74% | |||
| 2-Year Total Return | -99.91% | |||
| 3-Year Total Return | -99.98% | |||
| 5-Year Total Return | -99.98% | |||
| 52-Week High % Change | -99.92% | |||
| 52-Week Low % Change | 39,900.00% | |||
| Price | ELYS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.50 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Jul 24, 2024 | |||
| 52-Week High Price (Date) | Jan 27, 2025 | |||
| Valuation | ELYS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 16.52K | |||
| Enterprise Value | 2.62M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.54 | |||
| Earnings Per Share Growth | -28.23% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.01 | |||
| Enterprise Value/Revenue (TTM) | 0.06 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -0.23 | |||
| Enterprise Value/EBIT | -0.20 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ELYS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 31.89M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ELYS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 561 838 3325 | |||
| Address | 130 Adelaide Street West Toronto, ON M5H 2K4 | |||
| Website | elysgame.com | |||
| Country | Canada | |||
| Year Founded | 1998 | |||
| Profitability | ELYS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -30.64% | |||
| Profit Margin | -40.26% | |||
| Management Effectiveness | ELYS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -25.21% | |||
| Return on Equity | -- | |||
| Income Statement | ELYS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 42.74M | |||
| Total Revenue (TTM) | 42.74M | |||
| Revenue Per Share | $1.34 | |||
| Gross Profit (TTM) | 7.90M | |||
| EBITDA (TTM) | -11.54M | |||
| EBIT (TTM) | -13.10M | |||
| Net Income (TTM) | -17.21M | |||
| Net Income Avl. to Common (TTM) | -17.21M | |||
| Total Revenue Growth (Q YOY) | -11.75% | |||
| Earnings Growth (Q YOY) | 15.70% | |||
| EPS Diluted (TTM) | -0.54 | |||
| EPS Diluted Growth (Q YOY) | 27.06% | |||
| Balance Sheet | ELYS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.55M | |||
| Cash Per Share (Q) | $0.08 | |||
| Total Current Assets (Q) | 8.17M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 2.70M | |||
| Current Ratio (Q) | 0.613 | |||
| Book Value Per Share (Q) | $0.08 | |||
| Total Assets (Q) | 22.35M | |||
| Total Current Liabilities (Q) | 13.32M | |||
| Total Debt (Q) | 5.16M | |||
| Total Liabilities (Q) | 19.64M | |||
| Total Common Equity (Q) | 2.70M | |||
| Cash Flow | ELYS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -3.50M | |||
| Cash from Financing (TTM) | 2.34M | |||
| Net Change in Cash (TTM) | -2.48M | |||
| Levered Free Cash Flow (TTM) | -4.12M | |||
| Cash from Operations (TTM) | -2.36M | |||
